Segui
Sankar Mohan
Sankar Mohan
Director at Core Diagnostcis
Email verificata su corediagnostics.net
Titolo
Citata da
Citata da
Anno
The mutation spectrum revealed by paired genome sequences from a lung cancer patient
W Lee, Z Jiang, J Liu, PM Haverty, Y Guan, J Stinson, P Yue, Y Zhang, ...
Nature 465 (7297), 473-477, 2010
6352010
Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin
A Lai, S Kharbanda, WB Pope, A Tran, OE Solis, F Peale, WF Forrest, ...
Journal of clinical oncology 29 (34), 4482-4490, 2011
5422011
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
RM Lynch, E Boritz, EE Coates, A DeZure, P Madden, P Costner, ...
Science translational medicine 7 (319), 319ra206-319ra206, 2015
4752015
Exon Array Profiling Detects EML4-ALK Fusion in Breast, Colorectal, and Non–Small Cell Lung Cancers
E Lin, L Li, Y Guan, R Soriano, CS Rivers, S Mohan, A Pandita, J Tang, ...
Molecular Cancer Research 7 (9), 1466-1476, 2009
4242009
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India
A Patel, H Kaur, I Xess, JS Michael, J Savio, S Rudramurthy, R Singh, ...
Clinical microbiology and infection 26 (7), 944. e9-944. e15, 2020
4222020
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
Clinical & Experimental Immunology 182 (3), 289-301, 2015
2792015
Structural basis for substrate selectivity in human maltase-glucoamylase and sucrase-isomaltase N-terminal domains
L Sim, C Willemsma, S Mohan, HY Naim, BM Pinto, DR Rose
Journal of Biological Chemistry 285 (23), 17763-17770, 2010
2522010
New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes: structures and inhibition of human intestinal maltase-glucoamylase with compounds from …
L Sim, K Jayakanthan, S Mohan, R Nasi, BD Johnston, BM Pinto, ...
Biochemistry 49 (3), 443-451, 2010
2132010
Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models
JM Spoerke, C O'Brien, L Huw, H Koeppen, J Fridlyand, RK Brachmann, ...
Clinical cancer research 18 (24), 6771-6783, 2012
2092012
High d (+) glucose concentration inhibits RANKL-induced osteoclastogenesis
Y Wittrant, Y Gorin, K Woodruff, D Horn, HE Abboud, S Mohan, ...
Bone 42 (6), 1122-1130, 2008
1962008
COP1 is a tumour suppressor that causes degradation of ETS transcription factors
AC Vitari, KG Leong, K Newton, C Yee, K O’Rourke, J Liu, L Phu, R Vij, ...
Nature 474 (7351), 403-406, 2011
1792011
The PI 3 K/A kt/m TOR axis in head and neck cancer: functions, aberrations, cross‐talk, and therapies
R Vander Broek, S Mohan, DF Eytan, Z Chen, C Van Waes
Oral diseases 21 (7), 815-825, 2015
1762015
Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non–small cell lung cancer: MET expression levels are predictive of …
H Koeppen, W Yu, J Zha, A Pandita, E Penuel, L Rangell, R Raja, ...
Clinical Cancer Research 20 (17), 4488-4498, 2014
1482014
Degradation of the S. frugiperda peritrophic matrix by an inducible maize cysteine protease
S Mohan, PWK Ma, T Pechan, ER Bassford, WP Williams, DS Luthe
Journal of Insect Physiology 52 (1), 21-28, 2006
1422006
Zwitterionic glycosidase inhibitors: salacinol and related analogues
S Mohan, BM Pinto
Carbohydrate Research 342 (12-13), 1551-1580, 2007
1352007
Impact of insecticides on sucking pests and natural enemy complex of transgenic cotton
M Kannan, S Uthamasamy, S Mohan
Current Science, 726-729, 2004
1232004
Role of various flavonoids: Hypotheses on novel approach to treat diabetes
S Mohan, L Nandhakumar
Journal of Medical Hypotheses and Ideas 8 (1), 1-6, 2014
1222014
Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer
C O'Brien, G Cavet, A Pandita, X Hu, L Haydu, S Mohan, K Toy, CS Rivers, ...
Cancer research 68 (13), 5380-5389, 2008
1192008
Preliminary Immunomodulatory Activities of the Aqueous Extract of Terminalia chebula.
HN Shivaprasad, MD Kharya, AC Rana, S Mohan
Pharmaceutical Biology 44 (1), 32-34, 2006
1192006
Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles
S Mohan, S McAtamney, T Haselhorst, M von Itzstein, BM Pinto
Journal of medicinal chemistry 53 (20), 7377-7391, 2010
1092010
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20